Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 532-536, September 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, A. D.
Right arrow Articles by Winzler, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, A. D.
Right arrow Articles by Winzler, R. J.

The Effect of A-Methopterin on Formate-C14 Incorporation by Mouse Leukemias In Vitro*

Albert D. Williams, Grant G. Slater{dagger} and Richard J. Winzler

( Departments of Biological Chemistry, University of Illinois College of Medicine, Chicago, Illinois, and of Biochemistry and Nutrition, University of Southern California, Los Angeles, Calif.)

The in vitro incorporation of formate-C14 into the protein and lipids of several leukemic mouse tissues and of normal mouse liver has been studied. The folic acid analog, A-methopterin, has been shown to inhibit by 72 per cent the incorporation of formate-C14 into the protein of leukemic cells sensitive in vivo to A-methopterin. A-methopterin inhibited by 40 per cent the incorporation of the isotope into the proteins of a lymphoma resistant in vivo to A-methopterin therapy. There was no significant effect of A-methopterin on the incorporation of formate-C14 into the gross protein fraction of normal mouse liver.

The protein residue from the L1210-S lymphoma incubated in the presence and absence of A-methopterin was further fractionated to isolated pure methionine, serine, adenine, and guanine. Serine had the highest specific activity, with the purines having about 40 per cent as much activity as serine, and methionine about one-third of the activity of the purines. The inhibitory effect of A-methopterin on the incorporation of formate-C14 into ribonucleic acid purines was significantly greater than its effect on incorporation into serine and methionine.

* This work was supported by a grant from the National Institutes of Health of the United States Public Health Service.

{dagger} Present address: Institute for Medical Research, Cedars of Lebanon Hospital, Los Angeles, Calif.

Received 4/11/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.